| 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion CA Winstanley, DEH Theobald, JW Dalley, JC Glennon, TW Robbins Psychopharmacology 176, 376-385, 2004 | 384 | 2004 |
| Social brain, social dysfunction and social withdrawal S Porcelli, N Van Der Wee, S van der Werff, M Aghajani, JC Glennon, ... Neuroscience & Biobehavioral Reviews 97, 10-33, 2019 | 309 | 2019 |
| Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats CA Winstanley, Y Chudasama, JW Dalley, DEH Theobald, JC Glennon, ... Psychopharmacology 167, 304-314, 2003 | 269 | 2003 |
| Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats V Boulougouris, JC Glennon, TW Robbins Neuropsychopharmacology 33 (8), 2007-2019, 2008 | 239 | 2008 |
| Age‐related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild‐type mice R Minkeviciene, J Ihalainen, T Malm, O Matilainen, V Keksa‐Goldsteine, ... Journal of neurochemistry 105 (3), 584-594, 2008 | 224 | 2008 |
| Where is cingulate cortex? A cross-species view S van Heukelum, RB Mars, M Guthrie, JK Buitelaar, CF Beckmann, ... Trends in Neurosciences 43 (5), 285-299, 2020 | 189 | 2020 |
| Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task ESJ Robinson, JW Dalley, DEH Theobald, JC Glennon, MA Pezze, ... Neuropsychopharmacology 33 (10), 2398-2406, 2008 | 166 | 2008 |
| Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder MA van der Kooij, JC Glennon Neuroscience & Biobehavioral Reviews 31 (4), 597-618, 2007 | 160 | 2007 |
| A causal and mediation analysis of the comorbidity between attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) E Sokolova, AM Oerlemans, NN Rommelse, P Groot, CA Hartman, ... Journal of autism and developmental disorders 47, 1595-1604, 2017 | 155 | 2017 |
| Practitioner Review: Psychological treatments for children and adolescents with conduct disorder problems–a systematic review and meta‐analysis MJ Bakker, CU Greven, JK Buitelaar, JC Glennon Journal of child psychology and psychiatry 58 (1), 4-18, 2017 | 128 | 2017 |
| Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism J Naaijen, J Bralten, G Poelmans, JC Glennon, B Franke, JK Buitelaar Translational psychiatry 7 (1), e999-e999, 2017 | 128 | 2017 |
| Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: a review of magnetic resonance spectroscopy studies J Naaijen, DJ Lythgoe, H Amiri, JK Buitelaar, JC Glennon Neuroscience & Biobehavioral Reviews 52, 74-88, 2015 | 125 | 2015 |
| Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives MJ Kas, JC Glennon, J Buitelaar, E Ey, B Biemans, J Crawley, RH Ring, ... Psychopharmacology 231, 1125-1146, 2014 | 109 | 2014 |
| Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial K Okkersen, C Jimenez-Moreno, S Wenninger, F Daidj, J Glennon, ... The Lancet Neurology 17 (8), 671-680, 2018 | 105 | 2018 |
| Maternal substance use during pregnancy and offspring conduct problems: A meta-analysis IH Ruisch, A Dietrich, JC Glennon, JK Buitelaar, PJ Hoekstra Neuroscience & Biobehavioral Reviews 84, 325-336, 2018 | 101 | 2018 |
| Conduct disorders JK Buitelaar, KC Smeets, P Herpers, F Scheepers, J Glennon, ... European child & adolescent psychiatry 22, 49-54, 2013 | 95 | 2013 |
| A potential regulatory role for intronic microRNA-338-3p for its host gene encoding apoptosis-associated tyrosine kinase A Kos, NFM Olde Loohuis, ML Wieczorek, JC Glennon, GJM Martens, ... PloS one 7 (2), e31022, 2012 | 88 | 2012 |
| AKAPs integrate genetic findings for autism spectrum disorders G Poelmans, B Franke, DL Pauls, JC Glennon, JK Buitelaar Translational psychiatry 3 (6), e270-e270, 2013 | 83 | 2013 |
| SLV313 (1-(2, 3-dihydro-benzo [1, 4] dioxin-5-yl)-4-[5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A … AC McCreary, JC Glennon, CR Ashby, HY Meltzer, Z Li, JH Reinders, ... Neuropsychopharmacology 32 (1), 78-94, 2007 | 76 | 2007 |
| Long non-coding RNAs in neurodevelopmental disorders IIGM van deVondervoort, PM Gordebeke, N Khoshab, PHE Tiesinga, ... Frontiers in molecular neuroscience 6, 53, 2013 | 75 | 2013 |
